Amedeo's Top 20

Amedeo Smart

Independent Medical Education


28 September 2020

Multidisciplinary Journal Club

  1. Arterburn DE, Telem DA, Kushner RF, Courcoulas AP, et al.
    Benefits and Risks of Bariatric Surgery in Adults: A Review.
    JAMA 2020;324:879-887.

  1. Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, et al.
    Acute pancreatitis.
    Lancet 2020;396:726-734.

  2. Worobey M, Pekar J, Larsen BB, Nelson MI, et al.
    The emergence of SARS-CoV-2 in Europe and North America.
    Science 2020.

  3. Sperduto PW, Mesko S, Li J, Cagney D, et al.
    Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.
    J Clin Oncol 2020.

  4. Shahar-Nissan K, Pardo J, Peled O, Krause I, et al.
    Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
    Lancet 2020;396:779-785.

  1. Plett H, Filippova OT, Garbi A, Kommoss S, et al.
    Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study.
    Gynecol Oncol 2020.

  2. Mohiuddin M, Blyth FM, Degenhardt L, Di Forti M, et al.
    General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews.
    Pain 2020.

  3. Ghirardi V, Ronsini C, Trozzi R, Di Ilio C, et al.
    Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience.
    Cancer 2020.

  4. Riva A, Barcella V, Benatti SV, Capobianco M, et al.
    Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.
    Mult Scler 2020.

  5. Borghaei H, Langer CJ, Paz-Ares L, Rodriguez-Abreu D, et al.
    Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials.
    Cancer 2020.

  1. San Lee J, Lee H, Park S, Choe Y, et al.
    Association between APOE epsilon2 and Abeta burden in patients with Alzheimer- and Vascular-Type Cognitive Impairment.
    Neurology 2020.

  2. Goadsby PJ, Silberstein SD, Yeung PP, Cohen JM, et al.
    LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF FREMANEZUMAB IN MIGRAINE: A RANDOMIZED STUDY.
    Neurology 2020.

  3. Jansz TT, Noordzij M, Kramer A, Laruelle E, et al.
    Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry.
    Nephrol Dial Transplant 2020;35:488-495.

  4. Zhao Z, Zhang J, Jiang X, Wang L, et al.
    Is Endovascular Treatment Still Good for Ischemic Stroke in Real World?: A Meta-Analysis of Randomized Control Trial and Observational Study in the Last Decade.
    Stroke 2020.

  5. Sawaki M, Taira N, Uemura Y, Saito T, et al.
    Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients.
    J Clin Oncol 2020.

  1. Alessandra F, Campese N, Goebel G, Ndayisaba JP, et al.
    Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson's disease.
    Neurology 2020.

  2. Kim S, Shin SH, Santangelo B, Veronese M, et al.
    Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [(18)F]DOPA and [(11)C]raclopride PET study in first-episode psychosis.
    Mol Psychiatry 2020.

  3. Ziegeler C, Mehnert J, Asmussen K, May A, et al.
    Central effects of erenumab in migraine patients: An event-related functional imaging study.
    Neurology 2020.

  4. Robblee J, Devick KL, Mendez N, Potter J, et al.
    Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine.
    Headache 2020.

  5. Liu L, Fuller M, Behymer TP, Ng Y, et al.
    Selective Serotonin Reuptake Inhibitors and Intracerebral Hemorrhage Risk and Outcome.
    Stroke 2020;51:1135-1141.


more..


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016